SAN MATEO, Calif. – Evidation Health has launched the DiSCover Project to develop digital biomarkers for chronic pain severity, flare-ups and quality of life.
“We chose to focus on chronic pain because of its prevalence, national importance, and perhaps most importantly, the fact that it still lacks treatments and solutions that work for many patients,” said Claire Meunier, a project researcher, in a statement.
The DisCover Project is a one-year longitudinal case-control observational study to collect different types of data and form a new understanding of chronic pain.
Evidation Health will recruit 10,000 participants to participate in the virtual study. Participants will be asked to contribute monthly surveys on their health, medical history and current experience with pain, as well as data from activity trackers and health and fitness apps. Based on those contributions, participants may be asked to also add another wearable or sensor, use a new smartphone app, contribute a saliva or blood lab sample, record a phone conversation or take an at-home genetic test.
“By accounting for what’s inside a person as well as what they do and their surroundings, we get a fuller picture of the person and can quantify chronic pain biomarkers that could lead to better outcomes and care for these patients,” said Meunier.